Safety and drug quantification of the dapivirine vaginal ring and oral pre-exposure prophylaxis in breastfeeding mother–infant pairs (MTN-043): a phase 3B, open-label, randomised trial

https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(24)00306-0/abstract?utm_campaign=infocusalerts-obgyn&utm_medium=email&dgcid=hubspot_email_infocusalerts-obgyn_feature&_hsenc=p2ANqtz--9mJIhIFRWRZa3lTaSqZwLQl-pMaY02tlbc33VFHP3vS6yjNMuhNwlr6kQPV4MtgKQTDGGmQNLYmDhuvgYvNr5VXvJsw&_hsmi=352424484&utm_content=352424484&utm_source=hs_email